Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVL-865 crossover CO2 panic challenge trial in healthy volunteers
NL-OMON49640Active, not recruiting
- Sponsor
- Cerevel Therapeutics
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of darigabat in anxiety disorder and panic disorder (4 arms), sponsored by Cerevel Therapeutics. Started Oct 2020; status: active, not recruiting.
02
Drugs
darigabat
03
Conditions
anxiety disorderpanic disorder
Beyond the preview
Go deeper on NL-OMON49640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49640.